Xiang Wang

发表

Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis.

J. McNeill, K. Macleod, P. Nagareddy, 2009, Cardiovascular research.

Metalloproteinases: key and common mediators of multiple GPCRs and candidate therapeutic targets in models of hypertensive cardiac disease.

Ana-Maria Bosonea, C. Fernandez-Patron, Xiang Wang, 2012, Drug discovery today. Disease models.

Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?

Ana-Maria Bosonea, C. Fernandez-Patron, Xiang Wang, 2012, Current hypertension reviews.

Metalloproteinases in hypertension and cardiac disease: differential expression and mutual regulation.

Ana-Maria Bosonea, C. Fernandez-Patron, Xiang Wang, 2011, Drug discovery today. Disease models.

MMP-2 Mediates Angiotensin II–Induced Hypertension Under the Transcriptional Control of MMP-7 and TACE

G. Lopaschuk, Z. Kassiri, Tatsujiro Oka, 2011, Hypertension.

Tumor Necrosis Factor- –Converting Enzyme Is a Key Regulator of Agonist-Induced Cardiac Hypertrophy and Fibrosis

G. Lopaschuk, Z. Kassiri, Tatsujiro Oka, 2009 .

Matrix Metalloproteinase-7 and ADAM-12 (a Disintegrin and Metalloproteinase-12) Define a Signaling Axis in Agonist-Induced Hypertension and Cardiac Hypertrophy

A. Lopez-Campistrous, G. Lopaschuk, R. Schulz, 2009, Circulation.

Matrix Metalloproteinase-2 Negatively Regulates Cardiac Secreted Phospholipase A 2 to Modulate In fl ammation and Fever

M. Gelb, M. Murakami, R. Lehner, 2015 .

Matrix Metalloproteinase-2 Mediates a Mechanism of Metabolic Cardioprotection Consisting of Negative Regulation of the Sterol Regulatory Element–Binding Protein-2/3-Hydroxy-3-Methylglutaryl-CoA Reductase Pathway in the Heart

Z. Kassiri, A. Takawale, S. Hernández‐Anzaldo, 2015, Hypertension.

MMP‐2 inhibits PCSK9‐induced degradation of the LDL receptor in Hepa1‐c1c7 cells

Difei Sun, Da-wei Zhang, S. Hernández‐Anzaldo, 2015, FEBS letters.

via cAMP signaling pathways PI3-kinase/Akt modulates vascular smooth muscle tone

R. Gerszten, S. Dedhar, J. McNeill, 2015 .

Expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.

Tangchun Wu, L. Cao, Miao Yang, 2004, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

Insights into the Activity, Differential Expression, Mutual Regulation, and Functions of Matrix Metalloproteinases and A Disintegrin and Metalloproteinases in Hypertension and Cardiac Disease

Ana-Maria Bosonea, C. Fernandez-Patron, Xiang Wang, 2012, Journal of Vascular Research.

Loganin exerts a protective effect on ischemia–reperfusion‐induced acute kidney injury by regulating JAK2/STAT3 and Nrf2/HO‐1 signaling pathways

Juan Xiao, Xiang Wang, F. Huang, 2021, Drug development research.

Matrix Metalloproteinase‐2 Negatively Regulates Cardiac Secreted Phospholipase A2 to Modulate Inflammation and Fever

Makoto Murakami, Richard Lehner, Michael H. Gelb, 2015, Journal of the American Heart Association.

FNDC5 Attenuates Atherosclerotic Plaque Formation and Regulates PPARα/HO-1 in ApoE−/− Mice

Xiang Wang, Da-nan Liu, Yao Wang, 2023, Journal of Vascular Research.